Difference between revisions of "Team:Tongji China/Judging form"
| Line 14: | Line 14: | ||
<div class="background"> | <div class="background"> | ||
<div class="judgeTitle" style="margin-top:auto;"> | <div class="judgeTitle" style="margin-top:auto;"> | ||
| − | Bronze medal | + | <br>Bronze medal |
</div> | </div> | ||
<div class="judgeTitle2"> | <div class="judgeTitle2"> | ||
| Line 20: | Line 20: | ||
</div> | </div> | ||
<div class="content"> | <div class="content"> | ||
| − | We’ve successfully registered and will attend the Giant Jamboree. | + | We’ve successfully registered and will attend the Giant Jamboree.<br><br> |
</div> | </div> | ||
<div class="judgeTitle2"> | <div class="judgeTitle2"> | ||
| Line 27: | Line 27: | ||
<div class="content"> | <div class="content"> | ||
We have clear attributions.<br> | We have clear attributions.<br> | ||
| − | <a href="https://2018.igem.org/Team:Tongji_China/Attributions">https://2018.igem.org/Team:Tongji_China/Attributions</a> | + | <a href="https://2018.igem.org/Team:Tongji_China/Attributions">https://2018.igem.org/Team:Tongji_China/Attributions</a><br><br> |
</div> | </div> | ||
<div class="judgeTitle2"> | <div class="judgeTitle2"> | ||
| Line 34: | Line 34: | ||
<div class="content"> | <div class="content"> | ||
We’ve successfully participate in the 2018 InterLab Study.<br> | We’ve successfully participate in the 2018 InterLab Study.<br> | ||
| − | <a href="https://2018.igem.org/Team:Tongji_China/InterLab">https://2018.igem.org/Team:Tongji_China/InterLab</a> | + | <a href="https://2018.igem.org/Team:Tongji_China/InterLab">https://2018.igem.org/Team:Tongji_China/InterLab</a><br><br> |
</div> | </div> | ||
<div class="judgeTitle"> | <div class="judgeTitle"> | ||
| Line 43: | Line 43: | ||
</div> | </div> | ||
<div class="content"> | <div class="content"> | ||
| − | We’ve made several new biobricks relating to T3SS and immunization therapy and successfully submitted them. The number of them are | + | We’ve made several new biobricks relating to T3SS and immunization therapy and successfully submitted them. The number of them are<br><br> |
</div> | </div> | ||
<div class="judgeTitle2"> | <div class="judgeTitle2"> | ||
| Line 50: | Line 50: | ||
<div class="content"> | <div class="content"> | ||
We receive the assistance of ShanghaiTech, SJTU-BioX-Shanghai, SSTi-SZGD and CPU_CHINA. Also, we provide help to SDU-CHINA and SJTU-BioX-Shanghai.<br> | We receive the assistance of ShanghaiTech, SJTU-BioX-Shanghai, SSTi-SZGD and CPU_CHINA. Also, we provide help to SDU-CHINA and SJTU-BioX-Shanghai.<br> | ||
| − | <a href="https://2018.igem.org/Team:Tongji_China/Collaborations">https://2018.igem.org/Team:Tongji_China/Collaborations</a> | + | <a href="https://2018.igem.org/Team:Tongji_China/Collaborations">https://2018.igem.org/Team:Tongji_China/Collaborations</a><br><br> |
</div> | </div> | ||
<div class="judgeTitle2"> | <div class="judgeTitle2"> | ||
| Line 57: | Line 57: | ||
<div class="content"> | <div class="content"> | ||
We’ve done education work in high school and do some survey according to our projects.<br> | We’ve done education work in high school and do some survey according to our projects.<br> | ||
| − | <a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a> | + | <a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a><br><br> |
</div> | </div> | ||
<div class="judgeTitle"> | <div class="judgeTitle"> | ||
| Line 68: | Line 68: | ||
We’ve done survey both in society and in hospital and university. According to the attitude of the society and the advice of doctors and teachers, we made the further plan of our project. We’ve visited the Roche Co. and got the idea of our product. | We’ve done survey both in society and in hospital and university. According to the attitude of the society and the advice of doctors and teachers, we made the further plan of our project. We’ve visited the Roche Co. and got the idea of our product. | ||
<br> | <br> | ||
| − | <a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a> | + | <a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a><br><br> |
</div> | </div> | ||
<div class="judgeTitle2"> | <div class="judgeTitle2"> | ||
| Line 75: | Line 75: | ||
<div class="content"> | <div class="content"> | ||
We’ve made the model of the antigen and SNVs.<br> | We’ve made the model of the antigen and SNVs.<br> | ||
| − | <a href="https://2018.igem.org/Team:Tongji_China/Model">https://2018.igem.org/Team:Tongji_China/Model</a> | + | <a href="https://2018.igem.org/Team:Tongji_China/Model">https://2018.igem.org/Team:Tongji_China/Model</a><br><br> |
</div> | </div> | ||
<div class="judgeTitle2"> | <div class="judgeTitle2"> | ||
| Line 82: | Line 82: | ||
<div class="content"> | <div class="content"> | ||
We’ve done a series of experiments to make sure that the antigen can be transferred into APCs and will trigger the immunological reaction.<br> | We’ve done a series of experiments to make sure that the antigen can be transferred into APCs and will trigger the immunological reaction.<br> | ||
| − | <a href="https://2018.igem.org/Team:Tongji_China/Demonstrate">https://2018.igem.org/Team:Tongji_China/Demonstrate</a> | + | <a href="https://2018.igem.org/Team:Tongji_China/Demonstrate">https://2018.igem.org/Team:Tongji_China/Demonstrate</a><br><br> |
</div> | </div> | ||
</div> | </div> | ||
Revision as of 11:10, 11 October 2018
Bronze medal
Registration and Jamboree Attendance
We’ve successfully registered and will attend the Giant Jamboree.
Attributions
Characterization
We’ve successfully participate in the 2018 InterLab Study.
https://2018.igem.org/Team:Tongji_China/InterLab
https://2018.igem.org/Team:Tongji_China/InterLab
Silver medal
Validated Part
We’ve made several new biobricks relating to T3SS and immunization therapy and successfully submitted them. The number of them are
Collaboration
We receive the assistance of ShanghaiTech, SJTU-BioX-Shanghai, SSTi-SZGD and CPU_CHINA. Also, we provide help to SDU-CHINA and SJTU-BioX-Shanghai.
https://2018.igem.org/Team:Tongji_China/Collaborations
https://2018.igem.org/Team:Tongji_China/Collaborations
Human Practices
We’ve done education work in high school and do some survey according to our projects.
https://2018.igem.org/Team:Tongji_China/Human_Practices
https://2018.igem.org/Team:Tongji_China/Human_Practices
Gold medal
Integrated Human Practices
We’ve done survey both in society and in hospital and university. According to the attitude of the society and the advice of doctors and teachers, we made the further plan of our project. We’ve visited the Roche Co. and got the idea of our product.
https://2018.igem.org/Team:Tongji_China/Human_Practices
https://2018.igem.org/Team:Tongji_China/Human_Practices
Model Your Project
Demonstration of Your Work
We’ve done a series of experiments to make sure that the antigen can be transferred into APCs and will trigger the immunological reaction.
https://2018.igem.org/Team:Tongji_China/Demonstrate
https://2018.igem.org/Team:Tongji_China/Demonstrate